SOURCE: Signal Watch

Signal Watch

October 04, 2011 08:05 ET

Analytical Reports on Perrigo Co. and Auxilium Pharmaceuticals Inc. - Tough Economy Offers Opportunity in Generic Pharmaceuticals

NEW YORK, NY--(Marketwire - Oct 4, 2011) - www.SignalWatcher.com provides members with proprietary analysis of over 10,000 stocks which is updated every day. Today, members can receive their complimentary stock analysis on Perrigo Co. (NASDAQ: PRGO) and Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL). Sign up now on www.SignalWatcher.com to get your free reports on these stocks.

While many companies have been struggling amid global economic woes, some companies in the Drug Related Products Industry have seen significant gains. Many over-the-counter and generic pharmaceutical makers like Perrigo Co. have seen significant gains over the last year as cash strapped and under insured consumers look for ways to save money on medicine. Studies have shown that over 90 percent of first time generic drug buyers continue using those generic drugs. www.SignalWatcher.com gives traders a unique insight about Perrigo Co. by registering now at http://signalwatcher.com/PRGO/October042011.php.

www.SignalWatcher.com brings investors free classic analysis on Perrigo Co., Auxilium Pharmaceuticals Inc. and other companies within the Drug Related Products industry. This type of analysis is only a fragment of the information members have available to them. To learn more we encourage investors to sign up at http://signalwatcher.com/EmailSignup.php.

With a slew of prescription drug patents set to expire soon, many pharmaceutical companies are looking to bolster their generic product lines by acquiring competitors in the industry. Another factor that could benefit companies with a focus on over the counter drugs is the transition of several profitable prescription drugs to over-the-counter status.

Auxilium Pharmaceuticals Inc., a biopharmaceutical company, has not fared as well as compared to some of its peers in the Drug Related Products Industry over the last year. One of the main reasons behind this weak performance is the disappointing sales of its drugs meant to treat a debilitating hand condition. Some analysts are upgrading the company's outlook though on news that the same drug has shown promising results in treating Peyronie's disease. www.SignalWatcher.com gives traders a unique insight about Auxilium Pharmaceuticals Inc. by registering now at http://signalwatcher.com/AUXL/October042011.php.

About Signal Watch

Signal Watch's #1 goal is to help customers successfully engage the markets. For over 20 years, we have been developing the most powerful trading software available anywhere. But the software is only part of our mission. We also provide education and customer support designed to enable our customers to take control of their financial future.

Read our disclaimer by clicking on the following link http://www.signalwatch.com/disclaimers.aspx

Contact Information